# NSN 6505-00-062-3336: Furosemide Tablets

NSN 6505-00-062-3336 (also written 6505000623336; NIIN 00-062-3336) is a furosemide tablets in Federal Supply Class 6505, Drugs and Biologicals. 4 manufacturer part numbers from 4 suppliers are on record. It was last purchased in Sep 2026.

## Identification

- NSN: 6505-00-062-3336 (6505000623336)
- NIIN: 00-062-3336 (000623336)
- Item name: FUROSEMIDE TABLETS
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC 0 (observed 2026-10-10)
- Acquisition method code: 0

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | TABLETS 100.000 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS FUROSEMIDE ACTIVE INGREDIENT 40.000 |
| FEAT | SPECIAL FEATURES | W/CHILD-PROOF SAFETY CLOSURE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | FUROSEMIDE TABLETS USP 40 MG 100 TABLETS PER BOTTLE |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| NDC00054-4299-25 | 32655 | HIKMA PHARMACEUTICALS USA INC. | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC00378-0216-01 | 3KJG9 | MYLAN PHARMACEUTICALS INC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC30698-0060-01 | 4W8M6 | VALIDUS PHARMACEUTICALS, LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC42291-0469-01 | 4QGW8 | AVKARE LLC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-09-22 | [SPE2DX25D8022/SPE2D926F9269](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505000623336) | FUROSEMIDE TABLETS | CARDINAL HEALTH, INC. | $5.33 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505000623336&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505000623336
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-00-062-3336/
JSON: https://nsnexplorer.com/api/nsn/6505-00-062-3336.json